« Overcoming “Pre-Market Syndrome”: Promoting Better Post-Market Surveillance in an Evolving Drug Development Context »

Shannon Gibson & Trudo Lemmens, "Overcoming “Pre-Market Syndrome”: Promoting Better Post-Market Surveillance in an Evolving Drug Development Context" in Holly Fernandez Lynch & I. Glenn Cohen, eds, FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies (New York: Columbia University Press, 2015) 268-285

Ce contenu a été mis à jour le 26 août 2016 à 17 h 17 min.